Efficacy and Safety of Benralizumab for Patients with Severe Asthma Uncontrolled with High-Dosage Inhaled Corticosteroids and Long-acting b2-agonists (SIROCCO): A Randomised, Multicentre, Placebo-Controlled Phase 3 Trial

Daniel Har; J. Andrew Bird

doi:10.1542/PEDS.2017-2475LLLL

Efficacy and Safety of Benralizumab for Patients with Severe Asthma Uncontrolled with High-Dosage Inhaled Corticosteroids and Long-acting b2-agonists (SIROCCO): A Randomised, Multicentre, Placebo-Controlled Phase 3 Trial

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	S224-S225
Journal	Pediatrics
Volume	140
DOIs	https://doi.org/10.1542/PEDS.2017-2475LLLL
State	Published - Dec 1 2017

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health

Access to Document

10.1542/PEDS.2017-2475LLLL

Cite this

Efficacy and Safety of Benralizumab for Patients with Severe Asthma Uncontrolled with High-Dosage Inhaled Corticosteroids and Long-acting b2-agonists (SIROCCO): A Randomised, Multicentre, Placebo-Controlled Phase 3 Trial. / Har, Daniel; Bird, J. Andrew.
In: Pediatrics, Vol. 140, 01.12.2017, p. S224-S225.

Research output: Contribution to journal › Comment/debate › peer-review

@article{2dd6a1029a8d401289126edd34873539,

title = "Efficacy and Safety of Benralizumab for Patients with Severe Asthma Uncontrolled with High-Dosage Inhaled Corticosteroids and Long-acting b2-agonists (SIROCCO): A Randomised, Multicentre, Placebo-Controlled Phase 3 Trial",

author = "Daniel Har and Bird, {J. Andrew}",

year = "2017",

month = dec,

day = "1",

doi = "10.1542/PEDS.2017-2475LLLL",

language = "English (US)",

volume = "140",

pages = "S224--S225",

journal = "Pediatrics",

issn = "0031-4005",

publisher = "American Academy of Pediatrics",

}

TY - JOUR

T1 - Efficacy and Safety of Benralizumab for Patients with Severe Asthma Uncontrolled with High-Dosage Inhaled Corticosteroids and Long-acting b2-agonists (SIROCCO)

T2 - A Randomised, Multicentre, Placebo-Controlled Phase 3 Trial

AU - Har, Daniel

AU - Bird, J. Andrew

PY - 2017/12/1

Y1 - 2017/12/1

UR - http://www.scopus.com/inward/record.url?scp=85121275170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85121275170&partnerID=8YFLogxK

U2 - 10.1542/PEDS.2017-2475LLLL

DO - 10.1542/PEDS.2017-2475LLLL

M3 - Comment/debate

AN - SCOPUS:85121275170

SN - 0031-4005

VL - 140

SP - S224-S225

JO - Pediatrics

JF - Pediatrics

ER -

Efficacy and Safety of Benralizumab for Patients with Severe Asthma Uncontrolled with High-Dosage Inhaled Corticosteroids and Long-acting b2-agonists (SIROCCO): A Randomised, Multicentre, Placebo-Controlled Phase 3 Trial

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this